Stay updated on HMPL-689 in Lymphomas: Failed Standard - Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.

Latest updates to the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe record describes a completed Phase 1 study of HMPL-689 in patients with lymphoma, including its design, eligibility criteria, treatment arms, outcomes, and study locations in China.SummaryDifference48%

- Check20 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe site's displayed revision number changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision number was updated from v3.7.0 to v3.7.1; the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the usual study details. This indicates restricted access to the record, preventing viewers from accessing the study information on the page.SummaryDifference18%

Stay in the know with updates to HMPL-689 in Lymphomas: Failed Standard - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.